Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus

Susanna Esposito, Cristina Daleno, Claudia Tagliabue, Alessia Scala, Irene Picciolli, Francesca Taroni, Carlotta Galeone, Fausto Baldanti, Nicola Principi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Little is known about the proportion of pediatric pandemic A/H1N1/2009 influenza cases who showed seroconversion, the magnitude of this seroconversion, or the factors that can affect the antibody level evoked by the pandemic A/H1N1/2009 influenza. Aims of this study were to analyse antibody responses and the factors associated with high antibody titres in a cohort of children with naturally acquired A/H1N1/2009 influenza infection confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR). Results: Demographic, clinical and virologic data were collected from 69 otherwise healthy children with pandemic A/H1N1/2009 influenza (27 females, mean age SD: 5.01 4.55 years). Their antibody levels against pandemic A/H1N1/2009 and seasonal A/H1N1 influenza viruses were evaluated by measuring hemagglutination-inhibiting antibodies using standard assays. Sixty-four patients (92.8%) with pandemic A/H1N1/2009 influenza had A/H1N1/2009 antibody levels of 40, whereas only 28/69 (40.6%) were seroprotected against seasonal A/H1N1 influenza virus. Those who were seroprotected against seasonal A/H1N1 virus were significantly older, significantly more often hospitalised, had a diagnosis of pneumonia significantly more frequently, and were significantly more often treated with oseltamivir than those who were not seroprotected (p <0.05). The children with the most severe disease (assessed on the basis of a need for hospitalisation and a diagnosis of pneumonia) had the highest antibody response against pandemic A/H1N1/2009 influenza virus. Conclusions: Otherwise healthy children seem to show seroprotective antibody titres after natural infection with pandemic A/H1N1/2009 influenza virus. The strength of the immune response seems to be related to the severity of the disease, but not to previous seasonal A/H1N1 influenza immunity.

Original languageEnglish
Article number563
JournalVirology Journal
Volume8
DOIs
Publication statusPublished - 2011

Fingerprint

Pandemics
Orthomyxoviridae
Human Influenza
Antibody Formation
H1N1 Subtype Influenza A Virus
Antibodies
Pneumonia
Oseltamivir
Hemagglutination
Infection
Reverse Transcriptase Polymerase Chain Reaction
Immunity
Hospitalization
Demography
Pediatrics

Keywords

  • Children
  • Immune response
  • Influenza
  • Pandemic A/H1N1/2009 influenza virus
  • Pediatric infectious diseases

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Esposito, S., Daleno, C., Tagliabue, C., Scala, A., Picciolli, I., Taroni, F., ... Principi, N. (2011). Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus. Virology Journal, 8, [563]. https://doi.org/10.1186/1743-422X-8-563

Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus. / Esposito, Susanna; Daleno, Cristina; Tagliabue, Claudia; Scala, Alessia; Picciolli, Irene; Taroni, Francesca; Galeone, Carlotta; Baldanti, Fausto; Principi, Nicola.

In: Virology Journal, Vol. 8, 563, 2011.

Research output: Contribution to journalArticle

Esposito, S, Daleno, C, Tagliabue, C, Scala, A, Picciolli, I, Taroni, F, Galeone, C, Baldanti, F & Principi, N 2011, 'Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus', Virology Journal, vol. 8, 563. https://doi.org/10.1186/1743-422X-8-563
Esposito, Susanna ; Daleno, Cristina ; Tagliabue, Claudia ; Scala, Alessia ; Picciolli, Irene ; Taroni, Francesca ; Galeone, Carlotta ; Baldanti, Fausto ; Principi, Nicola. / Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus. In: Virology Journal. 2011 ; Vol. 8.
@article{52bf79fbc4684989a8b6c9013f31a015,
title = "Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus",
abstract = "Background: Little is known about the proportion of pediatric pandemic A/H1N1/2009 influenza cases who showed seroconversion, the magnitude of this seroconversion, or the factors that can affect the antibody level evoked by the pandemic A/H1N1/2009 influenza. Aims of this study were to analyse antibody responses and the factors associated with high antibody titres in a cohort of children with naturally acquired A/H1N1/2009 influenza infection confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR). Results: Demographic, clinical and virologic data were collected from 69 otherwise healthy children with pandemic A/H1N1/2009 influenza (27 females, mean age SD: 5.01 4.55 years). Their antibody levels against pandemic A/H1N1/2009 and seasonal A/H1N1 influenza viruses were evaluated by measuring hemagglutination-inhibiting antibodies using standard assays. Sixty-four patients (92.8{\%}) with pandemic A/H1N1/2009 influenza had A/H1N1/2009 antibody levels of 40, whereas only 28/69 (40.6{\%}) were seroprotected against seasonal A/H1N1 influenza virus. Those who were seroprotected against seasonal A/H1N1 virus were significantly older, significantly more often hospitalised, had a diagnosis of pneumonia significantly more frequently, and were significantly more often treated with oseltamivir than those who were not seroprotected (p <0.05). The children with the most severe disease (assessed on the basis of a need for hospitalisation and a diagnosis of pneumonia) had the highest antibody response against pandemic A/H1N1/2009 influenza virus. Conclusions: Otherwise healthy children seem to show seroprotective antibody titres after natural infection with pandemic A/H1N1/2009 influenza virus. The strength of the immune response seems to be related to the severity of the disease, but not to previous seasonal A/H1N1 influenza immunity.",
keywords = "Children, Immune response, Influenza, Pandemic A/H1N1/2009 influenza virus, Pediatric infectious diseases",
author = "Susanna Esposito and Cristina Daleno and Claudia Tagliabue and Alessia Scala and Irene Picciolli and Francesca Taroni and Carlotta Galeone and Fausto Baldanti and Nicola Principi",
year = "2011",
doi = "10.1186/1743-422X-8-563",
language = "English",
volume = "8",
journal = "Virology Journal",
issn = "1743-422X",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus

AU - Esposito, Susanna

AU - Daleno, Cristina

AU - Tagliabue, Claudia

AU - Scala, Alessia

AU - Picciolli, Irene

AU - Taroni, Francesca

AU - Galeone, Carlotta

AU - Baldanti, Fausto

AU - Principi, Nicola

PY - 2011

Y1 - 2011

N2 - Background: Little is known about the proportion of pediatric pandemic A/H1N1/2009 influenza cases who showed seroconversion, the magnitude of this seroconversion, or the factors that can affect the antibody level evoked by the pandemic A/H1N1/2009 influenza. Aims of this study were to analyse antibody responses and the factors associated with high antibody titres in a cohort of children with naturally acquired A/H1N1/2009 influenza infection confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR). Results: Demographic, clinical and virologic data were collected from 69 otherwise healthy children with pandemic A/H1N1/2009 influenza (27 females, mean age SD: 5.01 4.55 years). Their antibody levels against pandemic A/H1N1/2009 and seasonal A/H1N1 influenza viruses were evaluated by measuring hemagglutination-inhibiting antibodies using standard assays. Sixty-four patients (92.8%) with pandemic A/H1N1/2009 influenza had A/H1N1/2009 antibody levels of 40, whereas only 28/69 (40.6%) were seroprotected against seasonal A/H1N1 influenza virus. Those who were seroprotected against seasonal A/H1N1 virus were significantly older, significantly more often hospitalised, had a diagnosis of pneumonia significantly more frequently, and were significantly more often treated with oseltamivir than those who were not seroprotected (p <0.05). The children with the most severe disease (assessed on the basis of a need for hospitalisation and a diagnosis of pneumonia) had the highest antibody response against pandemic A/H1N1/2009 influenza virus. Conclusions: Otherwise healthy children seem to show seroprotective antibody titres after natural infection with pandemic A/H1N1/2009 influenza virus. The strength of the immune response seems to be related to the severity of the disease, but not to previous seasonal A/H1N1 influenza immunity.

AB - Background: Little is known about the proportion of pediatric pandemic A/H1N1/2009 influenza cases who showed seroconversion, the magnitude of this seroconversion, or the factors that can affect the antibody level evoked by the pandemic A/H1N1/2009 influenza. Aims of this study were to analyse antibody responses and the factors associated with high antibody titres in a cohort of children with naturally acquired A/H1N1/2009 influenza infection confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR). Results: Demographic, clinical and virologic data were collected from 69 otherwise healthy children with pandemic A/H1N1/2009 influenza (27 females, mean age SD: 5.01 4.55 years). Their antibody levels against pandemic A/H1N1/2009 and seasonal A/H1N1 influenza viruses were evaluated by measuring hemagglutination-inhibiting antibodies using standard assays. Sixty-four patients (92.8%) with pandemic A/H1N1/2009 influenza had A/H1N1/2009 antibody levels of 40, whereas only 28/69 (40.6%) were seroprotected against seasonal A/H1N1 influenza virus. Those who were seroprotected against seasonal A/H1N1 virus were significantly older, significantly more often hospitalised, had a diagnosis of pneumonia significantly more frequently, and were significantly more often treated with oseltamivir than those who were not seroprotected (p <0.05). The children with the most severe disease (assessed on the basis of a need for hospitalisation and a diagnosis of pneumonia) had the highest antibody response against pandemic A/H1N1/2009 influenza virus. Conclusions: Otherwise healthy children seem to show seroprotective antibody titres after natural infection with pandemic A/H1N1/2009 influenza virus. The strength of the immune response seems to be related to the severity of the disease, but not to previous seasonal A/H1N1 influenza immunity.

KW - Children

KW - Immune response

KW - Influenza

KW - Pandemic A/H1N1/2009 influenza virus

KW - Pediatric infectious diseases

UR - http://www.scopus.com/inward/record.url?scp=84855164867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855164867&partnerID=8YFLogxK

U2 - 10.1186/1743-422X-8-563

DO - 10.1186/1743-422X-8-563

M3 - Article

VL - 8

JO - Virology Journal

JF - Virology Journal

SN - 1743-422X

M1 - 563

ER -